Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: Delivering prevention services where most needed

2008 ◽  
Vol 19 ◽  
pp. 59-64 ◽  
Author(s):  
Faran Emmanuel ◽  
Mehreen Fatima
Addiction ◽  
2016 ◽  
Vol 112 (2) ◽  
pp. 290-298 ◽  
Author(s):  
Don C. Des Jarlais ◽  
Kamyar Arasteh ◽  
Courtney McKnight ◽  
Jonathan Feelemyer ◽  
Aimee N. C. Campbell ◽  
...  

AIDS ◽  
1994 ◽  
Vol 8 (4) ◽  
pp. 529-532 ◽  
Author(s):  
Nicholas H. Wright ◽  
Suphak Vanichseni ◽  
Pasakorn Akarasewi ◽  
Chantapong Was ◽  
Kachit Choopanya

2004 ◽  
Vol 15 (4) ◽  
pp. 280-282 ◽  
Author(s):  
Tasnim Azim ◽  
M Shah Alam ◽  
Motiur Rahman ◽  
M S Sarker ◽  
Giasuddin Ahmed ◽  
...  

2008 ◽  
Vol 13 (50) ◽  
Author(s):  
L Wiessing ◽  
M J van de Laar ◽  
M C Donoghoe ◽  
B Guarita ◽  
D Klempová ◽  
...  

The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Association (EFTA), the rates of reported newly diagnosed cases of HIV infection in IDUs are mostly at stable and low levels or in decline. In contrast, those rates increased in 2007 in many of the other (eastern) countries in the World Health Organization (WHO) European Region, suggesting that the HIV epidemic among IDUs in Europe is still growing. In countries or regions where indicators of HIV incidence show upward trends, existing prevention measures may be insufficient and in need of strengthening. In the EU/EFTA region the larger availability of harm reduction measures such as opioid substitution treatment and needle and syringe programmes may have played a key role in containing the epidemic among IDUs.


2011 ◽  
Vol 152 (4) ◽  
pp. 124-130 ◽  
Author(s):  
V. Anna Gyarmathy ◽  
József Rácz

In Hungary, there is a need for widely accessible HIV and HCV testing and counseling for injecting drug users. Theoretically, free and confidential rapid HIV and HCV testing would be the most suitable for this purpose. Low threshold agencies, such as needle and syringe programs, would provide ideal premises for such a testing system, Here, participants would be able to undergo regular testing every six months. Making rapid testing widely available raises the following three main issues: 1. validity of the testing results (or: the verification of positive rapid test results), 2. circumstances of taking blood (or: legislation regarding drawing blood), and 3. cost effectiveness (or: how important is it to prevent an HIV epidemic). The authors propose the establishment of a system that offers screening using rapid tests and which would be an expansion of a currently existing system of HIV and HCV testing based on finger prick blood. The current system would thus serve as a means to verify the results of the rapid tests. At the same time, there is a need to obtain permission from a public health body to enable in needle and syringe programs the provision of rapid testing and testing of blood using finger pricks. In many countries, test results are given to injecting drug users not by doctors but by trained social workers – such a system could also be established in Hungary. If preventing an HIV epidemic in Hungary is a priority, then wide access to rapid HIV testing is justified. Widely accessible free and confidential rapid HIV and HCV testing and counseling – combined with screening and verification using finger prick blood – may function not only as a testing and counseling service but also as a good quality public health monitoring system. Such a system, however, requires regular financial support from the government. Orv. Hetil., 2011, 152, 124–130.


Sign in / Sign up

Export Citation Format

Share Document